Search Saint Luke's

Advancing neuroscience research—a key goal at Saint Luke's has received a generous boost thanks to Kansas City, Missouri, resident Pat Brinker.

Application, requirements, and benefits for the Pharmacy Residency program at Saint Luke’s Health System.

As a faith-based health system, Saint Luke’s understands spiritual wellness plays a vital role in caring for patients. Saint Luke’s is a ministry of the Episcopal Diocese of West Missouri and practices a holistic care model that addresses patients’ physical, mental, and spiritual needs.

EpicCare Link is a web-based application that provides view-only access to patient records. EpicCare Link is now available to providers who are not on the medical staff with any of the Saint Luke’s facilities.

Lung Cancer
A081801 Integration of Immunotherapy into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO

Breast Cancer
A Phase 2 study of alisertib in combination with endocrine therapy in patients with HR+, HER2- negative recurrent or metastatic breast cancer. 

Colorectal Cancer 
M24-533: A Phase 2, Open-Label, Randomized, Master Protocol Study to Evaluate Safety and Efficacy of Multiple Treatment Combinations with ABBV-400 in Subjects with Metastatic Colorectal Cancer– Feasibility Request

Colorectal Cancer

A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

Pancreatic Cancer
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients with Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

Breast Cancer
A Phase I/II, multi-site, open-label, two-part trial to evaluate the efficacy, safety, and pharmacokinetics of BNT323 in combination with BNT327 in participants with advanced breast cancer.